Phase I/II Study of Anti-CD38 Monoclonal Antibody in Refractory Severe Aplastic Anemia

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Aplastic Anemia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Red Blood Cell Diseases Center and Regenerative Medicine Center, Tianjin, Tianjin Municipality, China
Contact: Study coordinator (Lele Zhang, PhD) · zhanglele@ihcams.ac.cn · 15811139278

Study leads

Jun Shi, PhD
Principal Investigator
Institute of Hematology & Blood Diseases Hosptial, Chinese Academy of Medical Science and Peking Union Medical School

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome

Severe Aplastic Anemia · Hypo-Plastic MDS · Myelodysplastic Syndrome (MDS)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Bethesda, United States

Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis

Severe Aplastic Anemia (SAA) · Hypo-Plastic Myelodysplastic Syndrome (MDS) · Paroxysmal Nocturnal Hemoglobinuria (PNH)

Abroad (travel likely)RecruitingPHASE2

Bethesda, United States

Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome

Aplastic Anemia · de Novo Myelodysplastic Syndrome · Myelodysplastic Syndrome

Abroad (travel likely)RecruitingPHASE2

Houston, United States

MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.

Severe Aplastic Anemia · Acquired Amegakaryocytic Thrombocytopenia · Acquired Pure Red Cell Aplasia

Abroad (travel likely)RecruitingPHASE2

Minneapolis, United States